نتایج جستجو برای: plasmablastic lymphoma

تعداد نتایج: 102389  

Journal: :Clinical advances in hematology & oncology : H&O 2012
Hasan Riaz Robert Zaiden Mohammad Khan Naeem Latif

Plasmablastic lymphoma (PBL) is listed in the World Health Organization (WHO) classification as a subtype of diffuse large B-cell lymphoma (DLBCL). Some morphologic features of PBL are similar to DLBCL; however, PBL has minimal or no expression of CD20 and leukocyte common antigen. Instead, PBL has been characterized by the plasmablastic morphology of the cancer cells, with high mitotic figures...

2012
Neeta Bagul G. S. Mamatha Aditi Mahalle

Oral plasmablastic lymphoma (PBL) is a rare malignancy, associated with HIV or other immunocompromised conditions. The lesion constituted a new subtype of diffuse large B-cell lymphoma and proposed a distinct entity based on its basic morphology, its clinical behaviour involving predominantly extramedullary sites (particularly oral cavity), and its limited antigenic phenotype data suggesting pl...

Journal: :Blood 2000
N Dupin T L Diss P Kellam M Tulliez M Q Du D Sicard R A Weiss P G Isaacson C Boshoff

Castleman disease (CD) is a lymphoproliferative disorder of unknown etiology that is associated with the development of secondary tumors, including B-cell lymphoma. Human herpesvirus 8 (HHV-8) (Kaposi's sarcoma-associated herpesvirus) sequences have been described in some cases of multicentric Castleman disease (MCD). Using a monoclonal antibody against an HHV-8-latent nuclear antigen, we show ...

2016
Dinkar Desai Siddharth Pandit Shiny Jasphin Akhil S. Shetty

Non-Hodgkin's lymphoma (NHL) is the third common malignant lesion of the oral region. Plasmablastic lymphomas are rare, aggressive neoplasms occurring mostly in human immunodeficiency virus (HIV) infected individual which accounts for approximately 2.6% of all NHL. It usually presents as a diffuse growth and with diffuse pattern of histological presentation. It is very difficult to differentiat...

Journal: :Clinical Case Reports 2017

2017
Xiao Han Minghui Duan Lixing Hu Daobin Zhou Wei Zhang

BACKGROUND Plasmablastic lymphoma (PBL) is a B-cell malignancy associated with human immunodeficiency virus (HIV). PBL could also influence the HIV-negative patients. The study aimed to identify prognostic factors for survival among Chinese PBL patients. MATERIALS AND METHODS Eligible patients from literature and Peking Union Medical College Hospital (PUMCH) were included in this study. Clini...

2012
A Bahari M Jahantigh A Mashhadi Z Bari AR Bari

BACKGROUND Plasmablastic lymphoma (PBL) is a relatively new entity, classified by WHO as a rare variant of diffuse large B cell lymphoma. The present case report introduces a 17 year old girl with chronic diarrhea, abdominal pain, intra-abdominal venous thromboses, ascites, mesenteric lymphadenopathies and small intestinal polyposis, the pathologic and immunohistochemistric examinations of the ...

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2018

2011
Hiroki Goto Shotaro Hagiwara Risen Hirai Takahiko Miyama Haruhito Honda Amane Tagashira Toshihiko Iizuka Makoto Mochizuki Katsuji Teruya Yoshimi Kikuchi Shinichi Oka Akiyoshi Miwa

Plasmablastic lymphoma is a rare and aggressive malignancy strongly associated with HIV infection. The refractory/relapsed disease rate is high, and the survival rate is characteristically poor. There are no satisfactory salvage regimens for relapsed cases. We successfully performed autologous stem cell transplantation using a regimen consisting of MCNU (ranimustine), etoposide, cytarabine, and...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید